Get the latest news, insights, and market updates on KRMD (KORU Medical Systems, Inc.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MAHWAH, N.J., January 05, 2026--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced inducement equity awards to Eric Schiller, Chief Technology Officer, pursuant to his previously announced employment agreement with the Company dated as of December 11, 2025. Jan 5, 2026 - $KRMD
KORU Medical Systems Announces 510(k) Submission for Clearance of the FreedomEDGE® System with a Commercialized Oncology Biologic
MAHWAH, N.J., December 30, 2025--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced the submission of a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) seeking clearance for the use of KORU Medical’s FreedomEDGE® infusion system to subcutaneously Dec 30, 2025 - $KRMD
KORU Medical Systems, Inc. Appoints Eric Schiller as Chief Technology Officer
MAHWAH, N.J., December 16, 2025--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on developing, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced the appointment of Eric Schiller as Chief Technology Officer, effective December 29, 2025. Dec 16, 2025 - $KRMD
KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE® Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025
MAHWAH, N.J., November 17, 2025--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will present its latest research at the ESID/EHA/SIOPE Focused Symposium 2025 in Vienna, Austria, November 18-20. The poster presentation, titled "Comparing Mechanical Pump and Manual Push for Short-Duration Subcutaneous Infusions: Nov 17, 2025 - $KRMD
3 Stocks Estimated To Be Trading Below Their Intrinsic Value In November 2025
In the current climate of mixed market performance, with the Dow Jones Industrial Average experiencing fluctuations and tech stocks facing valuation concerns, investors are keenly observing opportunities for potential undervalued assets. As we explore three stocks estimated to be trading below their intrinsic value in November 2025, understanding what constitutes a good investment becomes crucial—particularly in identifying companies that may offer strong fundamentals and growth potential... Nov 17, 2025 - $KRMD
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple